ULBP2–NKG2D signaling in cancer immunity: immune surveillance, immune escape, and therapeutic targeting
UL16-binding protein 2 (ULBP2) is a stress-inducible ligand of natural killer group 2 member D (NKG2D) that connects cellular stress to immune surveillance. Its consequences in cancer depend on membrane accessibility, ligand density, proteolytic shedding, soluble-ligand exposure, duration of stimulation, and effector-cell fitness rather than bulk expression alone. Accessible membrane ULBP2 can support NKG2D–DAP10-dependent natural killer (NK) cell cytotoxicity and CD8 + T-cell costimulation, whereas shedding reduces cell-surface ligand and can generate soluble ULBP2 (sULBP2). Chronic surface-ligand exposure has been associated with NKG2D adaptation in heterologous mouse models; direct human in-vivo validation and quantitative exposure thresholds remain unavailable. In clinical cohorts, associations between circulating sULBP2 and prognosis do not establish that sULBP2 itself mediates immunosuppression. This review distinguishes ULBP2-specific observations from pan-NKG2D-ligand findings and platform-based extrapolations. It critically evaluates molecular regulation, immune activation and escape, biomarker assays, and CAR-based therapies, multispecific engagers, antibodies, and antibody–drug conjugates (ADCs). EVOLVE104 recognizes ULBP2/5/6 and is under phase I investigation, but the available public sources contain no mature clinical efficacy or safety outcomes; ULBP2-specific CAR-T approaches remain preclinical and ULBP2-directed ADCs lack target-developability validation. Translation will require matched measurements of surface ULBP2 and sULBP2, human-relevant normal-tissue testing, functional immune readouts, and construct-specific assessment of target selectivity, internalization, and exposure.
Authors
- Haobo Han (ORCID: https://orcid.org/0000-0002-3328-7154)
- Weiwen Cai
- Ruohan Ma
- Biao Ding
- 焦作义
- Long Qin (ORCID: https://orcid.org/0000-0001-9995-7176)
Institutions
- Lanzhou University Second Hospital (CN)
- Lanzhou University (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2026-11-16
- DOI
- https://doi.org/10.3389/fimmu.2026.2012358
- Primary Topic
- Immune Cell Function and Interaction
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China